Mount Sinai Logo

Jacqueline Tamis-Holland

  • ASSISTANT PROFESSOR Medicine, Cardiology
Print ProfilePrint Profile

Certifications

  • American Board of Internal Medicine

Education

  • MD, * New York University School of Medicine *

  • Residency, Internal Medicine
    NYU Hospital Center

  • Fellowship, Cardiology
    Saint Luke's-Roosevelt Hospital Center

  • Fellowship, Interventional Cardiology
    St. Luke's - Roosevelt Hospital Center

Biography

    Dr. Jacqueline E. Tamis-Holland is an interventional cardiologist at Mount Sinai St. Luke’s and Mount Sinai Roosevelt Hospitals. She is the Associate Director for the Mount Sinai Saint Luke’s Cardiac Cath Labs as well as Program Director for the Interventional Cardiology Fellowship. In addition, she serves as the Director of Women’s Heart NY, a multi-site comprehensive program designed for women who are at risk for or have a history of heart disease.

    Dr Tamis-Holland is a spokesperson for the American Heart Association, and is on the writing committee for the American Heart Association/American College of Cardiology’s “Guidelines for ST Segment elevation Infarction”. She is also an executive committee member for the American Heart Association’s Mission Lifeline Program and a member of the medical leadership committee of the NYC Go Red for Women campaign. Dr Tamis-Holland serves on the American College of Cardiology’s Council for Academic Cardiology and Interventional Cardiology. She was recently rewarded a community out-reach grant from the American Heart Association to develop a family nutritional educational program for spanish speaking patients.

    Dr Tamis-Holland holds a post as Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She has lectured extensively on topics related to coronary artery disease at local and national cardiology meetings. Dr Tamis-Holland was voted teacher of the year by the Cardiology Fellows at St Luke’s and Roosevelt Hospitals.

    Dr. Tamis-Holland is also a skilled medical researcher. She has published numerous peer-reviewed articles and book chapters. She is a reviewer for the New England Journal of Medicine, the Journal of the American College of Cardiology and the American Heart Journal.

Awards

  • 2014 -
    American Heart Association, Heart of Our Mission Volunteer Award

  • 2014 -
    Luminary of the Heart, American Heart Association, Go Red for Women NYC

Research

Her research interests include acute coronary syndromes, and women and heart disease.

Publications

Nichols K, Tamis JE, DePuey EG, Mieres J, Malhotra S, and Rozanski A. Relationship of Gated SPECT Ventricular Function Parameters to Angiographic Measurements. J Nucl Cardiol 5:295-303, 1998.;.

Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Topol EJ, Califf RM. Sex, Clinical Presentation, and Outcome in Patients With Acute Coronary Syndromes. Global use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIB Investigators. N Engl J Med Jul 22;341(4):226-32, 1999.;.

Tamis JE, Steinberg JS. Atrial Fibrillation Independently Prolongs Hospital Stay after Coronary Artery Bypass Surgery. Clinic Cardiol 23:155-159, 2000.;.

Tamis-Holland JE, Homel P, Durani M, Iqbal, Sutandar A, Mindich BP, Steinberg JS. Atrial Fibrillation After Minimally Invasive Direct Coronary Artery Bypass. J Am Coll Cardiol 36: 1884-1888, 2000.;.

Balcetyte-Harris N, Tamis JE, Homel P, Menchavez E, and Steinberg JS. Randomized Study of Early Intravenous Esmolol versus Oral Beta-Blockers in Preventing Post-CABG Atrial Fibrillation in High Risk Patients Identified by the Signal-Averaged ECG: Results of a Pilot Study. A. N. E. 7:86-91, 2002..;.

Maniar PB, Balcetyte-Harris N, Tamis JE, and Steinberg JS. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev 2003;7:158-61.;.

Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Boland J, Ellis SG, and Hochman JS. Benefits of Direct Angioplasty for Women and Men with Acute Myocardial Infarction: Results of the GUSTO II-B PTCA Substudy. Am Heart J; 147:133-129, 2004.;.

Tamis-Holland JE, Kowalski M, Rill V, Firoozi K, and Steinberg JS. Patterns of Atrial Fibrillation After Cardiac Surgery: Impact on Length of Stay. A. N. E. 11;139-44, 2006 .;.

Syed T, Tamis-Holland J, Coven D, Hong MK, Can Glycopyrrolate Replace Temporary Pacemaker and Atropine. J Inv Cardiol 2008;20:19A–21A.;.

Bangalore S, Messerli, FH, Ou FS, Tamis-Holland J, Palazzo A, Roe, MT, Hong, MH, Peterson ED, for the CRUSADE Investigators. Blood Pressure Paradox in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: Results From 139,194 Patients in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) Quality Improvement Initiative. Am Heart J 2009;157(3):525-531..;.

Bangalore S, Messerli, FH, Ou FS, Tamis-Holland J, Palazzo A, Roe, MT, Hong, MH, Peterson ED, for the CRUSADE Investigators. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. European Heart Journal, 2009: DOI 10.1093/eurheart/ehp 397..;.

Aziz EA, Pulimi S, Coleman C, Florita C, Musat D, Tormey D, Fawzy A, Lee S, Herzog, E, Coven DL, Tamis-Holland J, Hong MK. Increased vascular complications in patients with renal dysfunction undergoing percutaneous coronary procedures using arteriotomy closure devices. J Inv Cardiol 2010:22;8-13..;.

Tamis-Holland JE, Lu J, Bittner V, Magee MF, Lopes N, Adler DS, Kip KE, Schwartz L, Groenewoud YA, Jacobs AK, for the BARI 2D Study Group. Sex, Clinical Symptoms, and Angiographic Findings in Patients with Diabetes Mellitus and Coronary Artery Disease (From the Bypass Angioplasty Revascularization Investigation [BARI] 2D). Am J Cardiol 2011;107:980-5.;.

Reynolds HR, Forman SA, Tamis-Holland JE, Steg PG, Mark DB, Pearte CA, Carvalho AC, Sopko G, Liu L, Lamas GA, Kruk M, Loboz-Grudzien K, Ruzyllo W, Hochman JS Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). Am Heart J. 2012 Mar;163(3):462-9.;.

O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol. 2013;61:e78-e140 .;.

O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Executive Summary. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol. 2013;61:485-510..;.

O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Executive Summary. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. 2013; 127: 529-555.;.

O’Gara P, Kushner FG, Ascheim DD, Casey DE, Chung MK, DeLemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornator JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, and Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation Circulation. 2013;127:e362-e425 .;.

O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovas Interv 2013;82e1-27. .;.

Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK, for the BARI 2D Study Group Sex Differences in Presentation and Outcome Among Patients with Type 2 Diabetes and Coronary Artery Disease Treated With Contemporary Medical Therapy With or Without Prompt Revascularization: A Report From BARI 2D. J Am Coll Cardiol 2013;61:1767-76 .;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Tamis-Holland did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central

Address

111 Amsterdam Ave
S&R 3
New York, NY 10025

Tel: 212-523-3007
Fax: 212-523-4007